Professor of Medicine David Geffen School of Medicine at UCLA Harbor-UCLA Medical Center
Infectious Disease
Dr. Mallory D. Witt, MD
|
|
Give Review
Mallory Witt practices Infectious Disease. She went to medical school at Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine She received awards:"Top Doctors:LA Area", "Top Doctors:Southern California", "Fellow (FIDSA)", "Fellow (FACP)" and "Super Doctor". Mallory Witt is a published MD as well. She has 102 publications published. The latest was: Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. Mallory Witt accepts all Medicare patients.
Publications
- Comparison of Insulin Resistance to Coronary Atherosclerosis in Human Immunodeficiency Virus Infected and Uninfected Men (from the Multicenter AIDS Cohort Study).
- Spontaneous Clearance of the Hepatitis C Virus Among Men Who Have Sex With Men.
- HIV infection is associated with an increased prevalence of coronary noncalcified plaque among participants with a coronary artery calcium score of zero: Multicenter A...
- Low-Density Lipoprotein Cholesterol Levels and Statin Treatment by HIV Status Among Multicenter AIDS Cohort Study Men.
- Differences in hepatitis C virus prevalence and clearance by mode of acquisition among men who have sex with men.
- Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis.
- Comparison of Racial Differences in Plaque Composition and Stenosis Between HIV-Positive and HIV-Negative Men from the Multicenter AIDS Cohort Study.
- Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression.
- Risk Factors for Fatty Liver in the Multicenter AIDS Cohort Study.
- Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men.
- Transcriptome analysis of HIV-infected peripheral blood monocytes: Gene transcripts and networks associated with neurocognitive functioning.
- Acute HIV-1 seroconversion with an unusual plasma biomarker profile.
- Reply to Bradshaw and Danta.
- Antiretroviral Therapy-Induced Changes in Plasma Lipids and the Risk of Kidney Dysfunction in HIV-Infected Men.
- A Comparison of MSM Stigma, HIV Stigma and Depression in HIV-Positive Latino and African American Men who have Sex with Men (MSM).
- Lipodystrophy and Inflammation Predict Later Grip Strength in HIV-Infected Men: the MACS Body Composition Sub-study.
- Incident Hepatitis C Virus Infection in Men Who Have Sex With Men: A Prospective Cohort Analysis, 1984-2011.
- Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study.
- Bioavailability of Extended-Release Nevirapine 400 and 300 mg in HIV-1: A Multicenter, Open-Label Study.
- Sex Hormones, Insulin Resistance, and Diabetes Mellitus Among Men With or at Risk for HIV Infection.
- Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia.
- Patient and provider characteristics associated with the decision of HIV coinfected patients to start hepatitis C treatment.
- Do social support, stress, disclosure and stigma influence retention in HIV care for Latino and African American men who have sex with men and women?
- Subcortical brain atrophy persists even in HAART-regulated HIV disease.
- Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus.
- Social support, stress and social network characteristics among HIV-positive Latino and African American women and men who have sex with men.
- Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial.
- Derivation and reliability of an instrument to estimate medical benefit of emergency treatment.
- HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.
- Factors that influence an HIV coinfected patient's decision to start hepatitis C treatment.
- Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men.
- Treat early or wait and monitor? A qualitative analysis of provider hepatitis C virus treatment decision-making in the context of HIV coinfection.
- Hepatitis B and long-term HIV outcomes in coinfected HAART recipients.
- Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy.
- Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: a substud...
- Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution.
- Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection.
- Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies.
- Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B.
- Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence.
- Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study.
- Sexual activity and Kaposi's sarcoma among human immunodeficiency virus type 1 and human herpesvirus type 8-coinfected men.
- Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression.
- Successful use of reduced-dose efavirenz in a patient with human immunodeficiency virus infection: case report and review of the literature.
- The costs of HIV antiretroviral therapy adherence programs and impact on health care utilization.
- Prospective study of attitudinal and relationship predictors of sexual risk in the multicenter AIDS cohort study.
- Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.
- A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients.
- Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women.
- Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy.
- A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain.
- A computer-based system to aid in the interpretation of plasma concentrations of antiretrovirals for therapeutic drug monitoring.
- Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.
- Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men.
- Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578).
- Recruiting minority men who have sex with men for HIV research: results from a 4-city campaign.
- A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.
- The effect of financial incentives on adherence with outpatient human immunodeficiency virus testing referrals from the emergency department.
- Recognition of undiagnosed HIV infection: an evaluation of missed opportunities in a predominantly urban minority population.
- Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study.
- A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575.
- Fatal fat embolism following amphotericin B lipid complex injection.
- Hepatopulmonary syndrome in HIV-hepatitis C virus coinfection: a case report and review of the literature.
- The feasibility of a community-based directly administered antiretroviral therapy program.
- Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.
- Changing pattern of AIDS: a bone marrow study.
- Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial.
- Evaluation of an emergency department referral system for outpatient HIV testing.
- Readmissions at a public safety net hospital.
- Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism.
- Factors Affecting Glomerular Filtration Rate, as Measured by Iohexol Disappearance, in Men with or at Risk for HIV Infection.
- Emergency department triage of patients infected with HIV.
- Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia.
- Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility te...
- Herpes simplex virus lymphadenitis: case report and review of the literature.
- The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis.
- HIV Monoinfection Is Associated With Increased Aspartate Aminotransferase-to-Platelet Ratio Index, a Surrogate Marker for Hepatic Fibrosis.
- Risk of opportunistic infection in the HAART era among HIV-infected Latinos born in the United States compared to Latinos born in Mexico and Central America.
- Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors.
- Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
- Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART.
- Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.
- Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole.
- Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients.
- The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, California.
- Cutaneous acanthamoebiasis in AIDS.
- Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review.
- Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.
- Amphotericin B: is a lipid-formulation gold standard feasible?
- HIV-2 infection with cerebral toxoplasmosis and lymphomatoid granulomatosis.
- Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa.
- Self-Reported Body Fat Change in HIV-Infected Men Is a Marker of Decline in Physical Health-Related Quality of Life with Aging, Independent of Co-Morbidity.
- Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.
- Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains.
- Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients.
- Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis.
- Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging.
- Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
- Age-related loss of olfactory sensitivity: association to dopamine transporter binding in putamen.
- Trains, travel, and the tubercle.
- Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection.
Schools
Stanford University
Harbor UCLA
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Top Doctors:LA Area
- Top Doctors:Southern California
- Fellow (FIDSA)
- Fellow (FACP)
- Super Doctor
Education
-
Harbor - UCLA Medical Center -
UCSF -
Stanford University School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center -
Harbor-UCLA Medical Center
Drug Facts
| NPI NUMBER | 1275687998 | |
| NPPES Provider LastName | WITT | |
| NPPES Provider FirstName | MALLORY | |
| NPPES Provider ZIPCode | 905022004 | |
| NPPES Provider State | CA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 197.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275687998 |
| Last Name Of The Provider | WITT |
| First Name Of The Provider | MALLORY |
| View All |
Similar Doctors
|
|
Dr. Addie B. Spier, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric S. Daar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael M. Nakata, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric S. Yang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clifford K. Beck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chin W. Jung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meena E. Lagnese, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Loren G. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James C. Ding, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward O. Blews III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer W. Hsu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mariasol Pena, MD |
|
|
Dr. Brad Spellberg, MD
This Doctor is OpenDoctor Recommended.
|